Your report shows your cancer’s genomic alterations detected in the blood. Associated FDA-approved therapies and drugs still in clinical trials are listed in the Professional Services part of the report where available.
Some of these genomic alterations may respond well to specific drugs; others make your cancer resistant to treatment.
Knowing which alterations are in your cancer helps your doctor plan the best treatment. Your physician will review the results to plan the best treatment option for you.
Note: These are samples of the first pages of a multi-page report available to patients in the patient portal. The full report includes information about clinical trials.
Guardant360CDx has an expected turnaround time of 7 days. Guardant360 is a slightly larger panel that has a turnaround time of about 10 days. Call 855.698.8887 or email [email protected] to learn more.